TSE:3349Consumer Retailing
The Bull Case For COSMOS Pharmaceutical (TSE:3349) Could Change Following Dividend Shift And 2027 Guidance
COSMOS Pharmaceutical Corporation recently reported full-year results for the year ended May 31, 2026, with sales of ¥1,099,583 million, net income of ¥32,046 million, and basic earnings per share of ¥404.33, alongside an increased annual dividend of ¥44.50 per share for fiscal 2026.
At the same time, the company outlined lower year-end dividend guidance of ¥42.00 per share and issued detailed earnings forecasts for fiscal 2027, giving investors clearer visibility into expected sales,...